Skip to main content

Table 2 Characteristics of the FXS NVIQ median-split subgroups

From: Auditory repetition suppression alterations in relation to cognitive functioning in fragile X syndrome: a combined EEG and machine learning approach

Variable ≤ 42 NVIQ group > 42 NVIQ group
N 8 (0 female) 6 (4 female)
Age range 9–32 years 10–22 years
Mean age (SD) 16.38 (± 7.37) 14.34 (± 4.08)
NVIQ range 32–42 52–93
Mean NVIQ (SD) 38 (± 3.64) 62 (± 10.02)
Medication N = 6
Methylphenidate (36–45 mg qd) (4)
Amphetamine mixed salts (50 mg qd) (1)
Venlafaxine (75 mg qd) (1)
N = 3
Methylphenidate (36–50 mg qd) (2)
Atomoxetine (25–40 mg qd) (2)
Citalopram (20 mg qd) (1)
Comorbidities Autistic spectrum disorder (4)
Attention-deficit hyperactivity disorder (6)
Autistic spectrum disorders (1)
Attention deficit hyperactivity disorder (3)